Historical index on Moscow Exchange :
C
"Should I invest in Public Joint-Stock Human Stem Cells Institute stock?"
"Should I trade "ISKJ" stock today?"
According to our live Forecast System,
Public Joint-Stock Company Human Stem Cells Institute stock is
a bad
long-term (1-year) investment*.
"ISKJ" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis.
Q&A about "ISKJ" projections.
See Our Other Forecasts
At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like
Public Joint-Stock Company Human Stem Cells Institute (ISKJ).
If you are looking for stocks with good return, Public Joint-Stock Company Human Stem Cells Institute
can be a bad, high-risk 1-year investment option.
Public Joint-Stock Company Human Stem Cells Institute quote is equal to
73.90 at 2026-02-16, but your current investment may be devalued in the future.
Based on our forecasts, a long-term decrease is expected,
the "ISKJ" stock price prognosis for 2031-02-16
is 13.38. With a 5-year investment, the revenue is expected to be around
-81.90%.
Your current $100 investment may be down to $18.10 in 2031.
Public Joint-Stock Company Human Stem Cells Institute Forecast,
Short-Term ISKJ Stock Price Prediction for Next Days and Weeks
Public Joint-Stock Company Human Stem Cells Institute Forecast,
Long-Term Price Predictions for Next Months and Year: 2026, 2027, 2028, 2029, 2030
ISKJ Target Price
Public Joint-Stock Company Human Stem Cells Institute price target in 14 days:
74.26* upside and
73.57* downside.
(Highest and lowest possible predicted price in a 14 day period)
Public Joint-Stock Company Human Stem Cells Institute forecast* for tomorrow, and next weeks based on the last 30 days
Company Name: Public Joint-Stock Company Human Stem Cells Institute Exchange: Moscow Exchange Industry: Biotechnology Sector: Healthcare Symbol: ISKJ Type: stock Website:https://hsci.ru
Pivot, Resistance and Support Levels
Calculation For Trading:
Resistance Level (R3): 75.72 Resistance Level (R2): 74.96 Resistance Level (R1): 74.52 Pivot Point: 73.76 Support Level (S1): 73.32 Support Level (S2): 72.56 Support Level (S3): 72.12
Term Box: Best Public Joint-Stock Company Human Stem Cells Institute forecast, ISKJ stock price prediction, ISKJ forecast, Public Joint-Stock Company Human Stem Cells Institute finance tips, ISKJ prediction, Public Joint-Stock Company Human Stem Cells Institute analyst report, ISKJ stock price predictions 2027, Public Joint-Stock Company Human Stem Cells Institute stock forecast, ISKJ forecast tomorrow, Public Joint-Stock Company Human Stem Cells Institute technical analysis, ISKJ stock future price, Public Joint-Stock Company Human Stem Cells Institute projections, Public Joint-Stock Company Human Stem Cells Institute market prognosis, ISKJ expected stock price.
Question Box: How will Public Joint-Stock Company Human Stem Cells Institute stock price increase? Will ISKJ price go up? Will Public Joint-Stock Company Human Stem Cells Institute stock price fall? Will ISKJ price drop? Will ISKJ stock price rise? Is Public Joint-Stock Company Human Stem Cells Institute price going up? Is Public Joint-Stock Company Human Stem Cells Institute a profitable investment? Is ISKJ stock price going to drop? When will ISKJ price fall? When will ISKJ stock price go down? When will Public Joint-Stock Company Human Stem Cells Institute price drop?
* Our share forecasts and predictions are made by Machine Learning & Ai, and shouldn't been used for financial decisions. We can't guarantee any profit.